These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8420036)

  • 1. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis.
    Mennander A; Räisänen A; Paavonen T; Häyry P
    Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
    Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis.
    Häyry P; Räisänen A; Ustinov J; Mennander A; Paavonen T
    FASEB J; 1993 Aug; 7(11):1055-60. PubMed ID: 8370476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
    Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
    J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic rejection in rat aortic allograft: mechanism of angiopeptin (BIM 23014C) inhibition on vascular smooth muscle cell proliferation in chronic rejection.
    Räisänen-Sokolowski A; Mennander A; Ustinov J; Paavonen T; Häyry P
    Transplant Proc; 1993 Feb; 25(1 Pt 2):944-5. PubMed ID: 8095115
    [No Abstract]   [Full Text] [Related]  

  • 6. Early inhibition of myointimal proliferation by angiopeptin after balloon catheter injury in the rabbit.
    Foegh ML; Asotra S; Conte JV; Howell M; Kagan E; Verma K; Ramwell PW
    J Vasc Surg; 1994 Jun; 19(6):1084-91. PubMed ID: 7911163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034.
    Lundergan C; Foegh ML; Vargas R; Eufemio M; Bormes GW; Kot PA; Ramwell PW
    Atherosclerosis; 1989 Nov; 80(1):49-55. PubMed ID: 2574977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
    Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
    Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.
    Lemström KB; Bruning JH; Bruggeman CA; Koskinen PK; Aho PT; Yilmaz S; Lautenschlager IT; Häyry PJ
    Circulation; 1994 Oct; 90(4):1969-78. PubMed ID: 7923687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.
    Lemström KB; Aho PT; Bruggeman CA; Häyry PJ
    Arterioscler Thromb; 1994 Dec; 14(12):2043-52. PubMed ID: 7981194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated.
    Mennander A; Paavonen T; Häyry P
    Arterioscler Thromb; 1993 Jul; 13(7):1019-25. PubMed ID: 8318503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide inhibition of myointimal proliferation by angiopeptin, a somatostatin analogue.
    Lundergan CF; Foegh ML; Ramwell PW
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):132B-136B. PubMed ID: 1673136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic rejection of rat aortic allografts. III. Synthesis of major eicosanoids by vascular wall components and effect of inhibition of the thromboxane cascade.
    Mennander A; Tiisala S; Ustinov J; Räisänen A; Paavonen T; Häyry P
    Arterioscler Thromb; 1992 Dec; 12(12):1380-6. PubMed ID: 1450170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619.
    Zhao Y; Foegh ML
    Prostaglandins; 1997 Nov; 54(5):781-93. PubMed ID: 9491208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts.
    Räisänen-Sokolowski AK; Pakkala IS; Samila SP; Binderup L; Häyry PJ; Pakkala ST
    Transplantation; 1997 Apr; 63(7):936-41. PubMed ID: 9112343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    J Clin Invest; 1993 Aug; 92(2):549-58. PubMed ID: 8394384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.
    Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T; Häyry P
    Arterioscler Thromb; 1991; 11(3):671-80. PubMed ID: 2029505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopeptin (BIM23014C) inhibits vascular smooth muscle cell migration in vitro through a G-protein-mediated pathway and is associated with inhibition of adenylyl cyclase and cyclic AMP accumulation.
    Mooradian DL; Fernandes B; Diglio CA; Lester BR
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):611-8. PubMed ID: 7596130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of allograft arteriosclerosis after retransplantation to donor strain.
    Mennander A; Häyry P
    Transplantation; 1996 Aug; 62(4):526-9. PubMed ID: 8781620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.